Finally, OCT4-PG1 pseudogene interfered with the expression of its parental gene OCT4 in the chemically modified CML cell line K562 resulting in altered expression of ABC transporters, involved in multidrug resistance of CML cells [49]. The gene discussed is ABCG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.